Article info

Download PDFPDF

Letter
IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS

Authors

  1. Correspondence to Dr C J Klein, Mayo Clinic, Rochester, MN 55905, USA; klein.christopher{at}mayo.edu
View Full Text

Citation

Shelly S, Mills JR, Martinez-Thompson JM, et al
IgM-gammopathy strongly favours immune treatable MMN and MADSAM over ALS

Publication history

  • Received September 3, 2019
  • Revised October 7, 2019
  • Accepted November 5, 2019
  • First published November 22, 2019.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.